Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 15,2x - 16,9x | 16,0x |
| Selected Fwd EBITDA Multiple | 9,9x - 10,9x | 10,4x |
| Fair Value | 131,21﷼ - 145,49﷼ | 138,35﷼ |
| Upside | 13,9% - 26,3% | 20,1% |
| Benchmarks | Ticker | Full Ticker |
| Al-Dawaa Medical Services Company | 4163 | SASE:4163 |
| Almunajem Foods Company | 4162 | SASE:4162 |
| BinDawood Holding Company | 4161 | SASE:4161 |
| Abdulaziz and Mansour Ibrahim Albabtin Co. | 9549 | SASE:9549 |
| Abdullah Al-Othaim Markets Company | 4001 | SASE:4001 |
| Nahdi Medical Company | 4164 | SASE:4164 |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| 4163 | 4162 | 4161 | 9549 | 4001 | 4164 | ||
| SASE:4163 | SASE:4162 | SASE:4161 | SASE:9549 | SASE:4001 | SASE:4164 | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | 4.6% | 8.9% | -6.9% | 6.6% | 2.7% | 3.2% | |
| 3Y CAGR | 10.4% | 7.5% | 2.9% | -14.3% | 8.1% | 1.8% | |
| Latest Twelve Months | 7.7% | -0.2% | -10.8% | -28.6% | 3.5% | -4.3% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 9.8% | 9.7% | 10.1% | 9.1% | 6.6% | 13.1% | |
| Prior Fiscal Year | 10.9% | 9.6% | 9.5% | 8.5% | 6.4% | 13.5% | |
| Latest Fiscal Year | 10.4% | 9.5% | 8.4% | 4.6% | 6.3% | 12.0% | |
| Latest Twelve Months | 10.4% | 9.5% | 8.4% | 4.1% | 6.3% | 12.0% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.41x | 1.58x | 1.61x | 0.99x | 1.05x | 1.65x | |
| EV / LTM EBITDA | 16.2x | 16.6x | 19.2x | 24.0x | 16.6x | 13.8x | |
| EV / LTM EBIT | 23.1x | 18.2x | 30.6x | 28.0x | 24.6x | 17.8x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | 16.2x | 16.6x | 24.0x | ||||
| Historical EV / LTM EBITDA | 13.8x | 16.1x | 18.9x | ||||
| Selected EV / LTM EBITDA | 15.2x | 16.0x | 16.9x | ||||
| (x) LTM EBITDA | 1,130 | 1,130 | 1,130 | ||||
| (=) Implied Enterprise Value | 17,227 | 18,134 | 19,040 | ||||
| (-) Non-shareholder Claims * | (573) | (573) | (573) | ||||
| (=) Equity Value | 16,654 | 17,561 | 18,468 | ||||
| (/) Shares Outstanding | 130.0 | 130.0 | 130.0 | ||||
| Implied Value Range | 128.11 | 135.08 | 142.06 | ||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 128.11 | 135.08 | 142.06 | 115.20 | |||
| Upside / (Downside) | 11.2% | 17.3% | 23.3% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4163 | 4162 | 4161 | 9549 | 4001 | 4164 | |
| Enterprise Value | 9,007 | 5,287 | 9,065 | 167 | 11,207 | 15,549 | |
| (+) Cash & Short Term Investments | 49 | 36 | 511 | 19 | 111 | 957 | |
| (+) Investments & Other | 65 | 0 | 0 | 4 | 307 | 0 | |
| (-) Debt | (2,100) | (104) | (2,285) | (40) | (2,782) | (1,530) | |
| (-) Other Liabilities | 0 | 0 | 0 | 0 | (42) | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 7,021 | 5,220 | 7,291 | 150 | 8,802 | 14,976 | |
| (/) Shares Outstanding | 85.0 | 60.0 | 1,141.0 | 3.4 | 900.0 | 130.0 | |
| Implied Stock Price | 82.60 | 87.00 | 6.39 | 44.00 | 9.78 | 115.20 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 82.60 | 87.00 | 6.39 | 44.00 | 9.78 | 115.20 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |